Over the last four years since the start of the pandemic, the Monell Chemical Senses Center, has developed different iterations of a rapid screening tool for detecting new-onset loss of smell. Since its launch in late 2020, several studies have validated its accuracy in detecting smell dysfunction and value as a tool for testing in large populations of people.
